A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Unicycive Therapeutics, Inc. (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. This fireside chat was recorded during the Lytham Partners 2026 Investor Healthcare Summit.
For this presentation we welcome Unicycive Therapeutics. Unicycive Therapeutics (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. This fireside chat was recorded during the Lytham Partners Spring 2025 Investor Conference.
During this fireside chat we welcome Unicycive Therapeutics (Nasdaq: UNCY). Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
During this fireside we welcome Unicycive Therapeutics. Unicycive (Nasdaq: UNCY) is a biotechnology company developing novel treatments for kidney diseases. Unicycive’s lead drug candidate, oxylanthanum carbonate (OLC), is a novel investigational phosphate binding...
In this presentation, we welcome Unicycive Therapeutics, Nasdaq ticker symbol UNCY. And with us today is their Chairman and CEO, Shalabh Gupta. Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. This Fireside Chat was...